Clinical trial
Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic…
NCT00010439 · Medical University of South Carolina, Other · Completed
Key facts
| NCT number | NCT00010439 |
|---|---|
| Title | Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis |
| Official title | A Non-Randomized, Open-Label, Prospective, Non-Controlled, 12-Month Clinical Trial to Determine the Effects of Alendronate 35 or 70 mg/Week Depending Upon Body Weight, in Children and Adolescent With IJO |
| Lead sponsor | Medical University of South Carolina, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | Alendronate |
| Enrollment | 10 |
| Start date | Sep 1, 2000 |
| Primary completion | Oct 1, 2003 |
| Completion | Nov 1, 2008 |
| First posted | Feb 2, 2001 |
| Last update posted | Nov 8, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: